Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.

Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.

OBJECTIVES: To determine the prevalence, determinants ofpositivity, and clinical utility of serum cryptococcal polysaccharide (CPS) antigen testing among HIV-infected patients in 2004 in Cambodia, an area highly endemic for cryptococcosis. METHODS: All HIV-infected patients with a CD4+ count &l...

Bibliografski detalji
Glavni autori:	Micol, R, Lortholary, O, Sar, B, Laureillard, D, Ngeth, C, Dousset, J, Chanroeun, H, Ferradini, L, Guerin, P, Dromer, F, Fontanet, A
Format:	Journal article
Jezik:	English
Izdano:	2007

Slični predmeti

Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007).
od: Micol, R, i dr.
Izdano: (2009)

Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era.
od: Caroline Charlier, i dr.
Izdano: (2008-01-01)

Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.
od: Rachel M Smith, i dr.
Izdano: (2013-01-01)

Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia
od: Miaomiao Xu, i dr.
Izdano: (2020-04-01)

Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand
od: Candice K. Kwan MD, i dr.
Izdano: (2014-09-01)

Asymptomatic cryptococcal antigenemia is associated with mortality among HIV‐positive patients in Indonesia
od: Ahmad Rizal Ganiem, i dr.
Izdano: (2014-01-01)

High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia.
od: Abere Shiferaw Alemu, i dr.
Izdano: (2013-01-01)

Cryptococcal antigenemia and susceptibility of Cryptococcuss neoformans to antifungal agents in HIV infection
od: A.O. Atayese, i dr.
Izdano: (2020-12-01)

Epidemiology of Cryptococcal antigenemia among HIV infected patients in southwestern Nigeria
od: Odekunle Bola Odegbemi, i dr.
Izdano: (2019-10-01)

Opportunistic Cryptococcal Antigenemia in the HAART Era at HIV Epidemic Settings of Northwest Ethiopia
od: Markos Negash, i dr.
Izdano: (2020-01-01)

Asymptomatic cryptococcal antigenemia in HIV-infected patients: a review of recent studies
od: Xiao-Lei Xu, i dr.
Izdano: (2020-12-01)

Epidemiology of Cryptococcal antigenemia among HIV infected patients in South-western Nigeria
od: O. Odegbemi, i dr.
Izdano: (2020-12-01)

Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV‐positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania
od: Kinanga A Magambo, i dr.
Izdano: (2014-01-01)

Prevalence of Cryptococcal Antigenemia and Lateral Flow Assay Accuracy in Severely Immunosuppressed AIDS Patients
od: Adriana Carla Garcia Negri, i dr.
Izdano: (2024-07-01)

A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria
od: Rita O. Oladele, i dr.
Izdano: (2023-01-01)

A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria.
od: Rita O Oladele, i dr.
Izdano: (2023-01-01)

{'en_US': 'Sero-prevalance of Cryptococcal Antigenemia in HIV Positive Individual having CD4 Counts <100 Cells/mm3'}
od: Sundar Khadka, i dr.
Izdano: (2021-12-01)

Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts
od: Martha P. Montgomery, i dr.
Izdano: (2017-06-01)

Prevalence of Cryptococcal Antigenemia and Associated Factors among HIV/AIDS Patients at Felege-Hiwot Referral Hospital, Bahir Dar, Northwest Ethiopia
od: Mohabaw Jemal, i dr.
Izdano: (2021-01-01)

Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review
od: Awoke Derbie, i dr.
Izdano: (2020-06-01)

Cryptococcal Antigenemia in Anti-Retroviral Naïve AIDS Patients: Prevalence and Its Association with CD4 Cell Count
od: Oghomwen Favour Osazuwa, i dr.
Izdano: (2012-05-01)

Cryptococcal Antigenemia in Anti-Retroviral Naïve AIDS Patients: Prevalence and Its Association with CD4 Cell Count
od: Evbaguehita Okuonghae, i dr.
Izdano: (2012-05-01)

Prevalence of Cryptococcal Antigenemia and associated factors among HIV/AIDS patients on second-line antiretroviral therapy at two hospitals in Western Oromia, Ethiopia.
od: Nuguse Geda, i dr.
Izdano: (2019-01-01)

Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3
od: James Wykowski, i dr.
Izdano: (2020-01-01)

CRYPTOCOCCAL ANTIGENEMIA IN HIV/AIDS PATIENTS USING LATERAL FLOW IMMUNOASSAY DETECTION AT Dr. SOETOMO GENERAL HOSPITAL SURABAYA
od: Sajuni Widjaja, i dr.
Izdano: (2018-03-01)

No association of cryptococcal antigenemia with poor outcomes among antiretroviral therapy-experienced HIV-infected patients in Addis Ababa, Ethiopia.
od: Christopher C Smitson, i dr.
Izdano: (2014-01-01)

Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia.
od: Romain Micol, i dr.
Izdano: (2010-11-01)

Prevalence and Associated Factors of Cryptococcal Antigenemia in HIV-Infected Patients with CD4 < 200 Cells/µL in São Paulo, Brazil: A Bayesian Analysis
od: Evanthia Vetos Mimicos, i dr.
Izdano: (2022-12-01)

Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda.
od: Elissa K Butler, i dr.
Izdano: (2012-01-01)

High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique.
od: Robert Deiss, i dr.
Izdano: (2021-01-01)

Correction: High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique.
od: Robert Deiss, i dr.
Izdano: (2024-01-01)

Correction: High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique
Izdano: (2024-01-01)

Six months survival and risk factors for attrition for patients detected with cryptococcal antigenemia through screening in Malawi.
od: Master R O Chisale, i dr.
Izdano: (2023-01-01)

Cryptococcal antigenemia screening among human immunodeficiency virus-infected cases with tuberculosis: Chance and cost effectiveness
od: Sora Yasri, i dr.
Izdano: (2018-01-01)

Screening for cryptococcal antigenemia and meningeal cryptococcosis, genetic characterization of Cryptococcus neoformans in asymptomatic patients with advanced HIV disease in Kinshasa, Democratic Republic of Congo
od: Bive Bive Zono, i dr.
Izdano: (2024-12-01)

Cryptococcal antigenemia and associated risk factors among ART‐naïve and ART‐experienced HIV‐infected peoples at selected health institutions of Mekelle, Northern Ethiopia
od: Kibra Hailu, i dr.
Izdano: (2019-06-01)

Molecular epidemiology of Group A Streptococcus infections in Cambodian children, 2007-2012.
od: Turner, P, i dr.
Izdano: (2015)

Cryptococcal meningitis: a neglected NTD?
od: Molloy, S, i dr.
Izdano: (2017)

Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa.
od: Bruce A Larson, i dr.
Izdano: (2016-01-01)

High prevalence of antimicrobial resistant Gram negative colonization in hospitalized Cambodian infants
od: Turner, P, i dr.
Izdano: (2016)